title: [Mid-term prognostic value of plasma heavy-chain myosin in thrombolysed myocardial infarction].
abstract: Plasma myosin heavy chain assay, which can be easily performed during the acute phase of myocardial infarction, is a recent method allowing quantitative assessment of the extent of infarction. However, to our knowledge, its prognostic value has not been studied in contrast with serum myosin light chain assay. We monitored the state of health of 40 patients (including 37 men with a mean age of 56 years) for two years after a first myocardial infarction, thrombolized during the acute phase. Their survival (mortality) and the development of "cardiac events" (MI, angina, sudden death, etc.) were evaluated at 2 years. The results observed at 2 years were correlated with the initial plasma myosin assay results and other direct and indirect methods of assessment of the extent of infarction, performed during the acute phase of myocardial infarction (cardiac enzymes, contrast angiography). The main result of this study is the demonstration that an unusual plasma myosin release kinetic (complex appearance) is predictive for the medium-term development of heart failure (p = 0.04) and/or destabilization of coronary insufficiency (p = 0.02). These results need to be emphasized, as with only 5 serum myosin assays performed over a 10-day period, it seems possible to identify a group of patients at high risk of medium-term complications, who possess a complex release kinetic during the acute phase of myocardial infarction and a value for area under the curve greater than 10.470 microliters U/L (cut-off value, p = 0.043).
authors.affiliation: Service de Cardiologie, Hôpital Arnaud De Villeneuve, CHU de Montpellier, 34295 Montpellier.
authors.forename: K
authors.initials: K
authors.lastname: Bendjelid
authors.forename: P
authors.initials: P
authors.lastname: Messner
authors.forename: J M
authors.initials: JM
authors.lastname: Stordeur
authors.forename: F
authors.initials: F
authors.lastname: Chapuis
authors.forename: P O
authors.initials: PO
authors.lastname: Kotzki
authors.forename: R
authors.initials: R
authors.lastname: Grolleau
mesh_terms: D000208:Acute Disease; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000097:blood*; D017023:Coronary Angiography; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011237:Predictive Value of Tests; D011379:Prognosis; D016016:Proportional Hazards Models; D015800:Protozoan Proteins; D012307:Risk Factors; D016019:Survival Analysis; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015800:Protozoan Proteins; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C033142:myosin-heavy-chain kinase; D003402:Creatine Kinase